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doi:10.1016/j.numecd.2010.05.003Abstract Background and aims: Early onset type 2 diabetes mellitus (T2DM) is associated
with obesity, insulin resistance and impaired beta-cell function. Non-alcoholic fatty liver
disease (NAFLD) may be an independent risk factor for T2DM. We investigated the relationship
between NAFLD and glucose metabolism in a large sample of obese children.
Methods and Results: A total of 571 obese children (57%males and 43% females) aged 8e18 years
were consecutively studied at a tertiary care centre specialised in paediatric obesity. Liver ultra-
sonographywas used to diagnoseNAFLDafter exclusion of hepatitis B andCandalcohol consump-
tion. Oral-glucose tolerance testing (OGTT) was performed; insulin sensitivity was evaluated by
using the insulin sensitivity index (ISI) andbeta-cell function by using the ratio between the incre-
mental areas under the curve (AUC) of insulin and glucose (incAUCins/incAUCglu). A total of 41%
of the obese children had NAFLD. Impaired glucose tolerance or T2DM was present in 25% of the
children with NAFLD versus 8% of those without it (p< 0.001). Children with NAFLD had higher
body mass index (BMI), fasting glucose, 120-min OGTT glucose, incAUCins/incAUCglu and lower
ISI as compared with children without NAFLD (p 0.002). At bootstrapped multivariable median
regression analysis controlling for gender, age, pubertal status and BMI, NAFLD was an indepen-
dent predictor of 120-min OGTT glucose and ISI, but not of incAUCins/incAUCglu. Similar findingssiologia Clinica, Consiglio Nazionale delle Ricerche, Via Moruzzi 1, 56100 Pisa, Italy. Tel.: þ39 050 31
A. Gastaldelli).
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571 obese children, Nutr Metab Cardwere obtained using continuous liver steatosis as the predictor, instead of dichotomous NAFLD.
Conclusion: NAFLD was present in 41% of our obese children and was associated with higher
insulin resistance, but not with impaired beta-cell function.
ª 2009 Elsevier B.V. All rights reserved.Introduction
Early-onset type 2 diabetes mellitus (T2DM) is charac-
terised by marked visceral obesity, extreme insulin resis-
tance and defective beta-cell function [1]. Non-alcoholic
fatty liver disease (NAFLD) may be an independent risk
factor for T2DM [2]. In the last decade, both obesity and
NAFLD have reached epidemic proportions, especially
among children and adolescents [3]. In adults, obesity is
associated with both glucose intolerance and NAFLD, which
may partly contribute to the current epidemic of cardio-
vascular disease [4e6]. In children, elevated levels of
serum aminotransferases e employed as surrogate markers
of NAFLD e are more common than in adults and cluster
with T2DM, hypertension and dyslipidaemia [7]. Since
glucose metabolism deteriorates more rapidly in children
than in adults, the identification of early metabolic defects
such as impaired fasting glucose (IFG) or impaired glucose
tolerance (IGT) in children is important to prevent the
development of diabetes, and possibly liver disease at
a later age [7].
Both insulin resistance and beta-cell dysfunction play an
important role in the progression from glucose intolerance
to diabetes. In populations with high prevalence of T2DM,
insulin resistance is well established long before the
development of any impairment in glucose homeostasis
[8,9]. In adults, beta-cell function is already decreased by
50% in normal glucose-tolerant individuals with 120-min
glucose concentration >100 mg dl1 during oral-glucose
tolerance testing (OGTT) [8,10]. Recent paediatric studies
have shown that not only obesity but also ectopic fat
accumulation, especially in the liver, may further deterio-
rate glucose homeostasis [11,12]. We, and others, have
shown that adults with NAFLD have decreased hepatic
insulin clearance and increased peripheral insulin concen-
tration in proportion to the degree of liver steatosis
detected by magnetic resonance imaging (MRI) [13].
The present study aimed at evaluating the association
between glucose tolerance, insulin resistance, beta-cell
function and NAFLD in a large group of Caucasian obese
children and adolescents.Methods
Subjects
A total of 571 children and adolescents were consecutively
enrolled into the study at the Division of Auxology, Istituto
Auxologico Italiano (Piancavallo, Verbania, Italy) between
February 2007 and February 2009. The entry criteria were:
(1) age 18 years and (2) body mass index (BMI) 95th
percentile for gender and age. The exclusion criteria were:
(1) genetic or syndromic obesity; (2) treatment with any
drugs; (3) alcohol consumption and; (4) presence ofdogni G, et al., Relationship betw
iovasc Dis (2010), doi:10.1016/j.nhepatitis B virus (HBV) or hepatitis C virus (HCV) infection.
The study protocol was approved by the local Ethics
Committee and parental consent was obtained.
Clinical examination
Pubertal status was classified as pre-pubertal (stage 1),
early pubertal (stages 2 and 3) or late pubertal (stages 4
and 5), according to Tanner [14]. Alcohol consumption
was determined by interview with the children and
parents. Weight and stature were measured following
standard procedures [15]. BMI was calculated as weight
(kg)/stature (m)2. Standard deviation scores (SDS) of
weight, stature and BMI were calculated using Italian
reference data [16].
Laboratory assessment
HBV surface antigen and antibodies against HCV were
measured to exclude hepatitis B and C [17]. Alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
gamma-glutamyl-transferase (GGT), total cholesterol,
high-density lipoprotein (HDL)-cholesterol, low-density
lipoprotein (LDL)-cholesterol and triglycerides were
measured using standard laboratory methods. Glucose
tolerance was assessed by means of an OGTT with 1.75 g of
glucose kg1 of weight (up to 75 g) [18]. Glucose and insulin
were measured at 0, 30, 60, 90 and 120 min during OGTT.
Glucose was measured using standard laboratory methods
and insulin using a chemiluminescent immunoassay
(Immulite 2000, Diagnostic Products Corporation, Los
Angeles, CA, USA). T2DM was defined as fasting glucose
126 mg dl1 or 120-min OGTT glucose 200 mg dl1; IFG
as fasting glucose between 100 and 126 mg dl1; and IGT as
120-min OGTT glucose between 140 and 200 mg dl1 [18].
The insulin sensitivity index (ISI) was calculated from OGTT
as described by Matsuda and DeFronzo [19]. The ratio
between the incremental AUCs of insulin and glucose
(incAUCins/incAUCglu) was used as surrogate index of beta-
cell function [8]. The quantitative insulin-sensitivity check
index (QUICKI) was also calculated to allow comparisons
with other studies [20].
Liver ultrasonography
Liver ultrasonography was performed by the same radiolo-
gist using the standard criteria [21,22]. Light steatosis was
defined as slightly increased liver echogenicity with normal
vessels and absent posterior attenuation; moderate stea-
tosis as moderately increased liver echogenicity with
partial dimming of vessels and early posterior attenuation;
and severe steatosis as diffusely increased liver echoge-
nicity with absence of visible vessels and heavy posterior
attenuation. Normal liver was defined as the absence ofeen fatty liver and glucose metabolism: A cross-sectional study in
umecd.2010.05.003
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operationally defined as any degree of liver steatosis in the
absence of HBV and HCV infection and alcohol intake.Statistical analysis
Values of continuous variables are given as median, inter-
quartile range (IQR) and minimum and maximum values
because of skewed distributions. IQR was calculated as the
difference between the 75th and 25th percentile. Between-
group comparisons of continuous variables were performed
with the WilcoxoneManneWhitney test and those of cate-
gorical variables with the Fisher’s exact test. Median regres-
sion was used to define the relationship between the three
outcomes of interest (120-min OGTT glucose, ISI and incAU-
Cins/incAUCglu) and NAFLD after accounting for potential
confounders (gender, age, pubertal status and BMI for all
models; fastingglucoseand fasting insulin for selectedmodels)
[23]. Four pre-specified regression models were evaluated:
Model 1A employed 120-minOGTT glucose as the outcomeand
NAFLD,gender,age,pubertal status,BMIand fastingglucoseas
predictors; Model 1B added insulin to the predictors of Model
1A; Model 2 had ISI as outcome and the same predictors of
Model 1A,exceptglucose;Model3had incAUCins/incAUCgluas
outcome and the same predictors of Model 2.
Because liver steatosis is a continuous outcome whose
categorisation as dichotomous variable (fatty liver ‘yes’ or
‘no’) may involve loss of information [25], we refitted theTable 1 Continuous measurements of the children with and wi
NAFLD (nZ 234)
Median IQR Min
Age (years) 15 4 8
Weight (kg) 103.2 31.6 54.3
Weight (SDS) 2.74 0.72 1.46
Height (m) 1.63 0.14 1.27
Height (SDS) 0.15 1.46 2.63
BMI (kg/m2) 38.1 8.5 27.8
BMI (SDS) 3.23 0.85 1.92
Fasting glucose (mg/dL) 78 11 54
120-min OGTT glucose (mg/dL) 122 33 80
Fasting insulin (mU/mL) 15 11 3
QUICKI 0.14 0.01 0.12
ISIa 8 5 2
incAUCins/incAUCglua 196 181 4
Cholesterol (mg/dL) 165 37 75
HDL-cholesterol (mg/dL) 43 12 24
LDL-cholesterol (mg/dL) 109 35 21
Triglycerides (mg/dL) 98 56 40
ALT (U/L) 37 30 7
AST (U/L) 26 14 9
GGT (U/L) 21 13 6
Abbreviations: NAFLD, non-alcoholic fatty liver disease; WMW tes
minimum value; Max, maximum value; SDS, standard deviation score;
quantitative insulin-sensitivity check index; ISI, insulin sensitivity in
under the curve of insulin and of glucose; ALT, alanine transaminase;
a Calculated using SI Units for insulin (pmol/L) and glucose (mmol/L
Please cite this article in press as: Bedogni G, et al., Relationship betw
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gorically coded steatosis. We tested whether a linear trend in
the severity of liver steatosis could be an adequate repre-
sentation of the association with the outcomes of interest
using a test for linear trend across the categorical levels of the
predictor [26]. Because a linear trend was detected for all
models, further analysis was performed with liver steatosis
modelled as the continuous predictor.
Because of heteroskedasticity, that is, inconstant
variance of residuals, 95% confidence intervals (95%CI) of
regression coefficients were calculated by bootstrapping
1000 random samples of 571 subjects [24]. All statistical
tests were two-tailed and statistical significance was set
to a value of p< 0.05. Statistical analysis was performed
using STATA 11 (STATA Corporation, College Station, TX,
USA).
Results
Characteristics of the study children
A total of 571 obese children (57% males and 43% females)
aged 8e18 years were consecutively enrolled into the study
at the Division of Auxology, Istituto Auxologico Italiano
(Piancavallo, Verbania, Italy). NAFLD was detected in 41%
of children (nZ 234). Liver steatosis was light in 10%
(nZ 58), moderate in 25% (nZ 140) and severe in 6%
(nZ 36) of the children.thout non-alcoholic fatty liver disease.
No NAFLD (nZ 337) WMW test
Max Median IQR Min Max p-value
18 15 3 8 18 0.986
177.0 91.1 23.5 45.2 155.3 <0.001
4.19 2.34 0.60 0.61 4.02 <0.001
1.89 1.61 0.12 1.33 1.97 <0.010
3.09 0.10 1.43 3.05 3.34 0.700
62.0 34.7 7.1 24.4 58.6 <0.001
5.13 2.84 0.80 1.68 4.46 <0.001
120 76 9 51 97 0.002
304 111 24 55 204 <0.001
82 11 7 2 73 <0.001
0.18 0.15 0.02 0.11 0.21 <0.001
28 12 7 3 39 <0.001
747 183 134 18 971 <0.001
258 162 43 74 287 0.688
80 48 14 24 113 <0.001
207 102 41 19 222 0.119
284 82 42 21 279 <0.001
245 20 12 6 327 <0.001
92 19 6 10 112 <0.001
133 15 7 2 166 <0.001
t, Wilcoxon-Mann-Whitney test; IQR, interquartile range; Min,
BMI, body mass index; OGTT, oral glucose tolerance test; QUICKI,
dex; incAUCins/incAUCglu, ratio between the incremental areas
AST, aspartate transaminase; GGT, gamma-glutamyl-transferase.
).
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Table 2 Categorical measurements of children with and without non-alcoholic fatty liver disease.
NAFLD (nZ 234) No NAFLD (nZ 337) Fisher’s Exact test, p-value
Gender (male/female) 139/95 105/232 <0.001
Tanner stage (pre-pub/early-pub/late-pub) 12/83/139 12/79/246 0.003
Normal/IFG/T2DM (with fasting glucose) 229/5/0 337/0/0 0.011
Normal/IGT/T2DM (with OGTT) 176/55/3 311/24/2 <0.001
The table gives the number of subjects with the characteristic of interest. Abbreviations: IFG, impaired fasting glucose; T2DM, type 2
diabetes mellitus; IGT, impaired glucose tolerance; NAFLD, non-alcoholic fatty liver disease; OGTT, oral glucose tolerance test.
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NAFLD
The measurements of the children with and without NAFLD
are given in Tables 1 and 2.
NAFLD was more frequent in males (p< 0.001), and
there was a different distribution of pubertal stages among
the children with and without NAFLD (pZ 0.003), even if
most of the subjects were postpubertal in both groups.
As compared with children without NAFLD, those with
NAFLD had higher BMI, fasting glucose, 120-min OGTT
glucose, fasting insulin, incAUCins/incAUCglu, triglycer-
ides, ALT, AST, GGT and lower values of QUICKI, ISI and HDL-
cholesterol (p 0.002 for all comparisons).
As detected by fasting glucose, only five children with
NAFLD had IFG and none had T2DM (pZ 0.011). As detected
by OGTT, 55 children (24%) with NAFLD and 24 children (7%)
without NAFLD had IGT, while the corresponding figures for
T2DM were three (1.3%) and two (0.6%) (p< 0.001),
respectively. Of the five children with IFG, three had IGT
and two T2DM at OGTT.Figure 1 Changes of glucose and insulin during oral glucose to
presence (broken line) of non-alcoholic fatty liver disease and the
mellitus. Values are medians and interquartile ranges. Abbrevia
tolerance; T2DM, type 2 diabetes mellitus.
Please cite this article in press as: Bedogni G, et al., Relationship betw
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NAFLD
Fig. 1 shows the OGTT curves of glucose and insulin
according to the presence of normal glucose tolerance
(NGT; nZ 487) or IGT/DM (nZ 79/5) in subjects with and
without NAFLD. No inferential analysis was performed on
these curves owing to the low number of subjects with IGT/
DM relative to the number of time points.
Fig. 2 shows the values of ISI and incAUCins/incAUCglu
according to NAFLD and glucose tolerance status. We
tested whether NAFLD contributed to ISI and incAUCins/
incAUCglu independently of IGT/DM by using boot-
strapped median regression with NAFLD and IGT/DM as
binary (yes vs. no) covariates. NAFLD decreased ISI of 3
(95% CI 4 to 2, p< 0.001) units independently of IGT/
DM (2, 95% CI 3 to 1 units, p< 0.001). NAFLD had,
however, no effect on incAUCins/incAUCglu (median
effectZ 16, 95% CI 9 to 41 units, pZ 0.201), contrary
to IGT/DM (median effectZ58, 95% CI 83 to 33
units, p< 0.001).lerance testing according to the absence (continuous line) or
absence or presence of impaired glucose tolerance or diabetes
tions: NGT, normal glucose tolerance; IGT, impaired glucose
een fatty liver and glucose metabolism: A cross-sectional study in
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Figure 2 Insulin sensitivity index and ratio between the incremental areas under the curve of insulin and glucose in children with
and without non-alcoholic fatty liver disease according to the absence or presence of impaired glucose tolerance or type 2 diabetes
mellitus. Box-plots give the median value (white), 25th and 75th percentiles (lower and upper limits of the box) and lower and
upper adjacent values (whiskers). Abbreviations: NGT, normal glucose tolerance; IGT/T2DM, impaired glucose tolerance/type 2
diabetes mellitus; NAFLD, non-alcoholic fatty liver disease; ISI,insulin sensitivity index; incAUCins/incAUCglu, ratio between the
incremental areas under the curve of insulin and glucose. At multivariable bootstrapped median regression, NAFLD contributed to
ISI but no to incAUCins/incAUCglu independently of glucose tolerance status (see text for measures of effect size).
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sensitivity, beta-cell function and NAFLD
Although the dichotomisation of glucose status as NGT
versus IGT/DM is clinically important [18], there is
substantial loss of power in modelling glucose status as
binary so that we performed further modelling using indi-
cators of glucose metabolism as continuous outcomes [25].
Table 3 reports the four models used to study the rela-
tionship between NAFLD and the outcomes of interest.
Model 1A evaluated which variables among NAFLD, gender,
age, pubertal status, BMI and fasting glucose were associ-
ated with 120-min OGTT glucose. Only NAFLD and fasting
glucose were predictors of 120-min OGTT glucose and the
presence of NAFLD increased 120-min OGTT of a median
value of 0.54 mmol l1 (p< 0.001). The addition of fasting
insulin to the above predictors (Model 1B) did not virtually
change these associations. Model 2 showed NAFLD to be
inversely associated with ISI with a median effect greater
than that of 1 SDS of BMI (3.11 vs.1.90 units, p< 0.001
for both). Importantly, Model 3 did not confirm the associ-
ation of incAUCins/incAUCglu with NAFLD.
Relationship between 120-min glucose, insulin
sensitivity, beta-cell function and liver steatosis
We refitted the Models in Table 3, replacing dichotomous
NAFLD with categorically coded steatosis (1Z none,
nZ 337; 2Z light or moderate, nZ 198; 3Z severe,
nZ 36). The results of these analyses were coherent with
those shown in Table 3. In the new Model 1A, only liverPlease cite this article in press as: Bedogni G, et al., Relationship betw
571 obese children, Nutr Metab Cardiovasc Dis (2010), doi:10.1016/j.nsteatosis (regression coefficient [b]Z 0.40, 95% CI
0.20e0.60, p< 0.001 for 1-level increase) and fasting
glucose (bZ 0.70, 95% CI 0.40e0.99, p< 0.001 for 1 mmol1
increase) were confirmed as predictors. Likewise, liver
steatosis (bZ 0.39, 95% CI 0.19e0.60, p< 0.001) and fasting
glucose (bZ 0.67, 95% CI 0.36e0.97, p< 0.001) were
confirmed as predictors in the new Model 1B. Moreover, liver
steatosis (bZ2.19, 95% CI 3.09 to 1.29, p< 0.001) and
BMI (bZ1.85, 95% CI 2.80 to 0.89, p< 0.001 for 1 SDS
increase) were confirmed as predictors for the New Model 2.
On thecontrary, noneof the testedpredictorswas associated
to the outcome in the New Model 3.
Discussion
Obese children are at greater risk of developing early onset
T2DM and cardiovascular disease [7,27]. Insulin resistance
plays a central role in glucose metabolism, but it is not until
deterioration of beta-cell function that glucose intolerance
and T2DM develop [10]. In adults, we have shown that an
impairment of beta-cell function is already present in NGT
subjects, and at the stage of IGT they have lost already 80%
of their beta-cell function [8]. Because obesity is often
associated with ectopic fat deposition [28], we studied the
association of NAFLD with glucose metabolism in a large
sample of Caucasian obese children.
Glucose metabolism and its association with fatty liver
were recently evaluated in 118 (37 males and 81 females)
obese children of different ethnic origins [11]. In this study,
insulin sensitivity was markedly reduced in obese children
with severe fatty liver, while the insulinogenic index e usedeen fatty liver and glucose metabolism: A cross-sectional study in
umecd.2010.05.003
Table 3 Multivariable prediction of glucose metabolism.
Model 1A Model 1B Model 2 Model 3
120-min OGTT glucose
(mmol/l)
120-min OGTT glucose
(mmol/l)
ISIa incAUCins/incAUCglua
NAFLD 0.54 [0.24 to 0.84]
p< 0.001
0.57 [0.29 to 0.85]
p< 0.001
3.11 [4.22 to 1.99]
p< 0.001
3.86 [37.00 to 29.29]
pZ 0.819
Male 0.07 [0.36 to 0.21]
pZ 0.605
0.11 [0.40 to 0.17]
pZ 0.431
0.16 [1.07 to 1.40]
pZ 0.794
6.90 [23.34 to 37.13]
pZ 0.654
Age (years) 0.05 [0.05 to 0.15]
pZ 0.315
0.06 [0.04 to 0.16]
pZ 0.210
0.20 [0.09 to 0.49]
pZ 0.180
2.42 [10.37 to 5.53]
pZ 0.550
Early pubertalb 0.10 [0.49 to 0.68]
pZ 0.747
0.21 [0.38 to 0.79]
pZ 0.488
1.87 [5.69 to 1.95]
pZ 0.336
44.59 [145.51 to 56.33]
pZ 0.386
Late pubertalb 0.29 [0.51 to 1.09]
pZ 0.479
0.39 [0.42 to 1.20]
pZ 0.344
0.73 [4.82 to 3.36]
pZ 0.725
70.11 [176.00 to 35.78]
pZ 0.194
BMI (SDS) 0.02 [0.23 to 0.19]
pZ 0.874
0.12 [0.37 to 0.12]
pZ 0.319
1.90 [2.95 to 0.86]
p< 0.001
15.46 [8.30 to 39.22]
pZ 0.202
Glucose (mmol/L) 0.66 [0.35 to 0.97]
p< 0.001
0.62 [0.31 to 0.94]
p< 0.001
 
Insulin (pmol/L)  0.002 [0.001 to 0.004]
pZ 0.184
 
Intercept 2.48 [0.80 to 4.16]
pZ 0.004
2.50 [0.82 to 4.18]
pZ 0.004
15.13 [10.21 to 20.05]
p< 0.001
241.95 [108.53 to 375.37]
p< 0.001
Values are regression coefficients and 95% confidence intervals obtained at bootstrapped median regression (see text for details).
Abbreviations: NAFLD, non-alcoholic fatty liver disease; OGTT, oral glucose tolerance test; ISI, insulin sensitivity index; incAUCins/
incAUCglu, ratio between the incremental areas under the curve of insulin and that of glucose.
a Calculated from insulin in pmol/L and glucose in mmol/L.
b vs. pre-pubertal.
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increase with the severity of liver steatosis but only to
a modest degree (pZ 0.05) [11].
In the present study, performed on a larger sample
(nZ 571) of children of the same ethnicity (Caucasians)
and studied at a single centre, we found that insulin
sensitivity was lower in children with NAFLD. However, the
apparent association of NAFLD with incAUCins/incAUCglu e
used as marker of beta-cell function e disappeared at
multivariable analysis after correction for potential
confounders. Only fasting glucose and NAFLD were predic-
tors of 120-min OGTT glucose, and this relationship was not
affected by fasting insulin. ISI was associated not only to
NAFLD but also to BMI, as we have recently reported for
children with histologically proven NAFLD [29]. These
findings were confirmed by modelling continuous liver
steatosis, instead of dichotomous NAFLD, as predictor.
Thus, in our study, the 120-min OGTT glucose concentration
of children with NAFLD was explained by greater insulin
resistance.
The main limitation of the present study, as well as of
the presently available paediatric studies, is that insulin
sensitivity and beta-cell function were obtained indirectly
from OGTT and not from reference methods such as the
euglycaemic hyperinsulinaemic clamp and the deconvolu-
tion of C-peptide. Although these surrogate indexes are
being increasingly used in children [11,12], they were
developed and validated in adults, and it is possible that
their paediatric application may have some limitations. On
the other hand, given the number and the age of the
subjects involved in the present study, it was neitherPlease cite this article in press as: Bedogni G, et al., Relationship betw
571 obese children, Nutr Metab Cardiovasc Dis (2010), doi:10.1016/j.nethically possible nor logistically feasible to perform the
euglycaemic hyperinsulinaemic clamp to assess insulin
sensitivity. A second limitation is that ultrasonography is
known to underestimate the prevalence of fatty liver and,
more importantly, does not offer any information on the
presence of non-alcoholic steatohepatitis and liver fibrosis
[17]. A third limitation of this study is the lack of body
composition measurements, including measurements of
visceral fat. The degree of obesity of our children also
impeded us to use waist circumference as a surrogate
measure of visceral fat [17]. Further studies are clearly
needed to disentangle the association of body composition
and insulin resistance in children with NAFLD [11,30].
In conclusion, 41% of our obese children had NAFLD and
its presence was associated with higher insulin resistance
but not with impaired beta-cell function. Our findings
suggest that obese children may need to be considered for
an evaluation of glucose metabolism. Further studies,
ideally performed with reference methods, are needed to
better define the status of beta-cell function in obese
children with NAFLD.Acknowledgements
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